Effect Of Chronobıologıcal Nutrıtıon On Premature Babıes

NCT ID: NCT05849948

Last Updated: 2023-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

94 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-01

Study Completion Date

2024-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine the effect of chronobiological nutrition approach on the growth and breastfeeding processes of premature babies. It will be carried out in a randomized controlled experimental design. In the study, it is planned to have 2 groups as experimental and control. As a result of the power analysis using the G Power 3.0.10 program, 90% power; A total of at least 78 samples were found to be sufficient in the study with a 5% margin of error (n1: 39; n2: 39). However, considering that the case could be lost, it was decided to increase it by 20% to 94 babies. Infants will be assigned to groups using a stratified sequential block randomization method. Premature babies will be stratified by week of gestation, birth weight and sex, and then an equal number of babies will be assigned to each group by blocking.

The appointment of premature infants will be decided by sequential block randomization.

After the descriptive information of the babies assigned to the groups is recorded in the questionnaire, the experimental group will be fed by applying the chronobiological nutrition approach. The control group will be fed without applying the chronobiological nutrition approach. The discharge times will be calculated for both groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nutrition, Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

choronobiological nutrition group

newborns were fed according to chronobiological nutrition

Group Type EXPERIMENTAL

choronobiological nutrition

Intervention Type BEHAVIORAL

Providing infant nutrition in accordance with crinobiological nutrition

control group

newborns will be fed in the order in which breastmilk is delivered to the hospital

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

choronobiological nutrition

Providing infant nutrition in accordance with crinobiological nutrition

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being treated in the NICU
* Gestation week is between 30 and 36
* The delivery took place in the hospital where the study was conducted.
* 70% of the daily enteral feeding is done with breast milk

Exclusion Criteria

* The baby is less than 30 weeks of gestation and greater than 36 weeks of gestation.
* Having neurological sequelae
* Having Grade 4 intraventricular bleeding
* The development of problems such as sepsis, NEC, which may change the general condition
* Being followed in invasive mechanical ventilation
* Receiving narcotic analgesics and sedation
* The baby has been shipped from outside
* Having undergone gastrointestinal (GIS) surgery or having GIS anomaly
Minimum Eligible Age

30 Weeks

Maximum Eligible Age

36 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eskisehir Osmangazi University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ezgi Ayvaz

NURSE

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ezgi Ayvaz

Role: CONTACT

05423787400

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

YENİDOĞAN DOKTORA TEZ

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

FETAL MOVEMENT COUNTING
NCT05361265 COMPLETED NA